EGFR 	EGFR 	 NNP	B-NP
/ 	/ 	 NNP	O
HER2  	HER2  	 NNP	B-NP
inhibitors  	inhibitors  	 VBD	I-NP
effectively  	effectively  	 RB	O
reduce  	reduce  	 VB	O
the  	the  	 DT	O
malignant  	malignant  	 JJ	O
potential  	potential  	 NN	O
of  	of  	 IN	O
MDR  	MDR  	 NNP	B-NP
breast  	breast  	 NN	I-NP
cancer  	cancer  	 NN	I-NP
evoked  	evoked  	 NN	I-NP
by  	by  	 IN	O
P-gp  	P-gp  	 JJ	B-NP
substrates  	substrates  	 JJ	I-NP
in vitro and in vivo  	in vitro and in vivo  	 NNP	O
Multidrug  	Multidrug  	 NNP	B-NP
resistance  	resistance  	 NN	I-NP
( 	( 	 -LRB-	O
MDR 	MDR 	 NNP	B-NP
)  	)  	 -RRB-	O
induced  	induced  	 VBN	O
by  	by  	 IN	O
chemotherapy  	chemotherapy  	 NN	O
in  	in  	 IN	O
breast  	breast  	 JJ	O
cancer  	cancer  	 NN	O
frequently  	frequently  	 RB	O
leads  	leads  	 VBZ	O
to  	to  	 TO	O
tumor  	tumor  	 NN	B-NP
invasion 	invasion 	 NN	I-NP
,  	,  	 ,	O
metastasis  	metastasis  	 NN	B-NP
and  	and  	 CC	O
poor  	poor  	 JJ	O
clinical  	clinical  	 JJ	B-NP
outcome 	outcome 	 NN	I-NP
.  	.  	 .	O
We  	We  	 PRP	O
preliminarily  	preliminarily  	 VBP	O
found  	found  	 VBN	O
that  	that  	 IN	O
the  	the  	 DT	O
epidermal  	epidermal  	 JJ	B-NP
growth  	growth  	 NN	I-NP
factor  	factor  	 NN	I-NP
receptor  	receptor  	 NN	I-NP
( 	( 	 -LRB-	O
EGFR 	EGFR 	 NNP	B-NP
)  	)  	 -RRB-	O
is  	is  	 VBZ	O
involved  	involved  	 VBN	O
in  	in  	 IN	O
enhancing  	enhancing  	 VBG	O
the  	the  	 DT	O
malignant  	malignant  	 JJ	O
potential  	potential  	 NN	O
of  	of  	 IN	O
MDR  	MDR  	 NNP	B-NP
breast  	breast  	 NN	I-NP
cancer  	cancer  	 NN	I-NP
cells 	cells 	 NNS	I-NP
,  	,  	 ,	O
but  	but  	 CC	O
the  	the  	 DT	O
mechanism  	mechanism  	 NN	O
remains  	remains  	 VBZ	O
unclear 	unclear 	 JJ	O
.  	.  	 .	O
In  	In  	 IN	O
the  	the  	 DT	O
present  	present  	 JJ	O
study 	study 	 NN	O
,  	,  	 ,	O
we  	we  	 PRP	O
demonstrated  	demonstrated  	 VBD	O
in vitro and in vivo  	in vitro and in vivo  	 CD	O
that  	that  	 IN	O
EGFR 	EGFR 	 NNP	B-NP
/ 	/ 	 NNP	O
HER2  	HER2  	 NNP	B-NP
promote  	promote  	 VB	O
the  	the  	 DT	O
invasive  	invasive  	 NN	O
and  	and  	 CC	O
metastatic  	metastatic  	 JJ	B-NP
abilities  	abilities  	 NNS	I-NP
of  	of  	 IN	I-NP
MDR  	MDR  	 NNP	I-NP
breast  	breast  	 NN	I-NP
cancer 	cancer 	 NN	I-NP
.  	.  	 .	O
More  	More  	 RBR	O
importantly 	importantly 	 RB	O
,  	,  	 ,	O
a  	a  	 DT	O
new  	new  	 JJ	O
function  	function  	 NN	O
of  	of  	 IN	O
EGFR 	EGFR 	 NNP	B-NP
/ 	/ 	 NNP	O
HER2  	HER2  	 NNP	B-NP
inhibitors  	inhibitors  	 NN	I-NP
was  	was  	 VBD	O
revealed  	revealed  	 VBN	O
for  	for  	 IN	O
the  	the  	 DT	O
first  	first  	 JJ	O
time 	time 	 NN	O
,  	,  	 ,	O
which  	which  	 WDT	O
could  	could  	 MD	O
improve  	improve  	 VB	O
the  	the  	 DT	O
treatment  	treatment  	 NN	B-NP
efficacy  	efficacy  	 NN	I-NP
of  	of  	 IN	O
breast  	breast  	 JJ	O
cancer  	cancer  	 NN	O
by  	by  	 IN	O
reversing  	reversing  	 VBG	O
the  	the  	 DT	O
MDR  	MDR  	 NNP	B-NP
process  	process  	 NN	I-NP
rather  	rather  	 RB	O
than  	than  	 IN	O
by  	by  	 IN	O
inhibiting  	inhibiting  	 JJ	O
tumor  	tumor  	 NN	B-NP
growth 	growth 	 NN	I-NP
.  	.  	 .	O
Firstly 	Firstly 	 NNP	O
,  	,  	 ,	O
using  	using  	 VBG	O
quantitative  	quantitative  	 JJ	O
real‑time  	real‑time  	 NNP	O
PCR  	PCR  	 NNP	O
and  	and  	 CC	O
western  	western  	 JJ	O
blot  	blot  	 JJ	O
analysis 	analysis 	 NN	O
,  	,  	 ,	O
we  	we  	 PRP	O
found  	found  	 VBD	O
that  	that  	 DT	O
overexpression  	overexpression  	 NN	B-NP
of  	of  	 IN	I-NP
EGFR 	EGFR 	 NNP	I-NP
/ 	/ 	 FW	O
HER2  	HER2  	 FW	B-NP
in  	in  	 FW	O
MCF7 	MCF7 	 FW	B-NP
/ 	/ 	 FW	O
Adr  	Adr  	 FW	B-NP
cells  	cells  	 FW	I-NP
upregulated  	upregulated  	 FW	O
CD147  	CD147  	 FW	B-NP
and  	and  	 CC	O
MMP2 	MMP2 	 CD	B-NP
/ 	/ 	 CD	O
9  	9  	 CD	O
at  	at  	 IN	O
both  	both  	 PDT	O
the  	the  	 DT	O
transcription  	transcription  	 NN	B-NP
and  	and  	 CC	O
protein  	protein  	 NN	B-NP
expression  	expression  	 NN	I-NP
levels 	levels 	 NNS	I-NP
,  	,  	 ,	O
which  	which  	 WDT	O
promoted  	promoted  	 VBD	B-NP
tumor  	tumor  	 JJ	I-NP
cell  	cell  	 NN	I-NP
migration 	migration 	 NN	I-NP
,  	,  	 ,	O
as  	as  	 RB	O
determined  	determined  	 VBN	O
using  	using  	 VBG	O
an  	an  	 DT	O
in vitro  	in vitro  	 JJ	O
invasion  	invasion  	 NN	O
assay 	assay 	 NN	O
.  	.  	 .	O
Secondly 	Secondly 	 RB	O
,  	,  	 ,	O
the  	the  	 DT	O
upregulated  	upregulated  	 JJ	B-NP
levels  	levels  	 NNS	I-NP
of  	of  	 IN	I-NP
CD147  	CD147  	 NNP	I-NP
and  	and  	 CC	O
MMP2 	MMP2 	 CD	B-NP
/ 	/ 	 CD	O
9  	9  	 CD	O
were  	were  	 VBD	O
decreased  	decreased  	 VBN	O
when  	when  	 WRB	O
EGFR 	EGFR 	 NNP	B-NP
/ 	/ 	 NNP	O
HER2  	HER2  	 NNP	B-NP
activity  	activity  	 NN	I-NP
was  	was  	 VBD	O
inhibited 	inhibited 	 CD	O
,  	,  	 ,	O
and  	and  	 CC	O
therefore  	therefore  	 RB	O
tumor  	tumor  	 JJ	B-NP
invasion  	invasion  	 NN	I-NP
was  	was  	 VBD	O
also  	also  	 RB	O
significantly  	significantly  	 RB	O
inhibited 	inhibited 	 VBD	O
.  	.  	 .	O
These  	These  	 DT	O
phenomena  	phenomena  	 NN	O
were  	were  	 VBD	O
also  	also  	 RB	O
demonstrated  	demonstrated  	 VBN	O
in  	in  	 IN	O
nude  	nude  	 JJ	O
mouse  	mouse  	 NN	O
assays 	assays 	 NN	O
.  	.  	 .	O
Additionally 	Additionally 	 RB	O
,  	,  	 ,	O
in  	in  	 IN	O
MDR  	MDR  	 NNP	B-NP
breast  	breast  	 NN	I-NP
cancer  	cancer  	 NN	I-NP
patients 	patients 	 NNS	I-NP
,  	,  	 ,	O
we  	we  	 PRP	O
found  	found  	 VBD	O
that  	that  	 DT	O
overexpression  	overexpression  	 NN	B-NP
of  	of  	 IN	I-NP
EGFR  	EGFR  	 NNP	I-NP
and  	and  	 CC	O
P‑gp  	P‑gp  	 CD	O
levels  	levels  	 NNS	O
led  	led  	 VBN	O
to  	to  	 TO	O
shorter  	shorter  	 VB	O
overall  	overall  	 JJ	B-NP
survival  	survival  	 NN	I-NP
( 	( 	 -LRB-	O
OS 	OS 	 NNP	B-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
disease‑free  	disease‑free  	 CD	B-NP
survival  	survival  	 NN	I-NP
( 	( 	 -LRB-	O
DFS 	DFS 	 NNP	B-NP
)  	)  	 -RRB-	O
by  	by  	 IN	O
IHC  	IHC  	 NNP	B-NP
assays  	assays  	 NN	I-NP
and  	and  	 CC	O
Kaplan‑Meier  	Kaplan‑Meier  	 CD	O
survival  	survival  	 NN	O
analysis 	analysis 	 NN	O
.  	.  	 .	O
In  	In  	 IN	O
conclusion 	conclusion 	 NN	O
,  	,  	 ,	O
EGFR 	EGFR 	 NNP	B-NP
/ 	/ 	 NNP	O
HER2  	HER2  	 NNP	B-NP
play  	play  	 VB	O
a  	a  	 DT	O
crucial  	crucial  	 JJ	O
role  	role  	 NN	O
in  	in  	 IN	O
enhancing  	enhancing  	 VBG	B-NP
CD147  	CD147  	 NNP	I-NP
and  	and  	 CC	O
MMP  	MMP  	 NNP	B-NP
expression  	expression  	 NN	I-NP
to  	to  	 TO	O
establish  	establish  	 VB	O
favorable  	favorable  	 JJ	O
conditions  	conditions  	 NNS	O
for  	for  	 IN	O
invasion 	invasion 	 CD	B-NP
/ 	/ 	 CD	I-NP
metastasis  	metastasis  	 NN	I-NP
in  	in  	 IN	O
MDR  	MDR  	 NNP	B-NP
breast  	breast  	 NN	I-NP
cancer 	cancer 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
scope  	scope  	 NN	O
of  	of  	 IN	O
application  	application  	 NN	O
of  	of  	 IN	O
EGFR 	EGFR 	 NNP	B-NP
/ 	/ 	 NNP	O
HER2  	HER2  	 NNP	B-NP
inhibitors  	inhibitors  	 NN	I-NP
may  	may  	 MD	O
be  	be  	 VB	O
expanded  	expanded  	 VBN	O
in  	in  	 IN	O
EGFR 	EGFR 	 NNP	B-NP
/ 	/ 	 CD	O
HER2‑positive  	HER2‑positive  	 CD	B-NP
patients 	patients 	 NNS	O
.  	.  	 .	O
We  	We  	 PRP	O
suggest  	suggest  	 VBP	O
that  	that  	 IN	O
MDR  	MDR  	 NNP	B-NP
breast  	breast  	 NN	I-NP
cancer  	cancer  	 NN	I-NP
patients  	patients  	 NNS	I-NP
may  	may  	 MD	O
benefit  	benefit  	 VB	O
from  	from  	 IN	O
novel  	novel  	 NN	O
therapies  	therapies  	 NNS	O
targeting  	targeting  	 VBG	B-NP
EGFR 	EGFR 	 NNP	I-NP
/ 	/ 	 NNP	O
HER2 	HER2 	 NNP	B-NP
.  	.  	 .	O
